Nakano Eriko, Mukai Kosuke, Fukuhara Atsunori, Otsuki Michio, Shimomura Iichiro, Ichijo Takamasa, Tsuiki Mika, Wada Norio, Yoneda Takashi, Takeda Yoshiyu, Oki Kenji, Yamada Tetsuya, Ogawa Yoshihiro, Yabe Daisuke, Kakutani Miki, Sone Masakatsu, Katabami Takuyuki, Tanabe Akiyo, Naruse Mitsuhide
Department of Metabolic Medicine, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan.
Department of Adipose Management, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan.
Endocr J. 2024 May 23;71(5):489-497. doi: 10.1507/endocrj.EJ23-0659. Epub 2024 Mar 14.
Aldosterone secretion in primary aldosteronism (PA) is often regulated by adrenocorticotropic hormone (ACTH) in addition to its autonomous secretion. However, the clinical characteristics and risk of cardiovascular and cerebrovascular (CCV) events in PA patients with aldosterone responsiveness to ACTH stimulation remain unclear. This study aimed to investigate the prevalence of CCV events in PA patients with high aldosterone responsiveness to ACTH stimulation. A retrospective cross-sectional study was conducted as part of the Japan Primary Aldosteronism Study/Japan Rare Intractable Adrenal Disease project. PA patients with adrenal venous sampling (AVS) between January 2006 and March 2019 were enrolled. The ACTH-stimulated plasma aldosterone concentration (PAC) of the inferior vena cava during AVS was used to evaluate aldosterone responsiveness to ACTH. We analyzed the relationship between responsiveness and previous CCV events. Logistic regression analysis demonstrated that the ΔPAC (the difference between the PAC measurements before and after ACTH stimulation) significantly increased the odds of previous CCV events in PA patients after adjusting for classical CCV event risk factors, baseline PAC and duration of hypertension (relative PAC: odds ratio [OR], 2.896; 95% confidence interval [CI], 0.989-8.482; ΔPAC: OR, 2.344; 95% CI, 1.149-4.780; ACTH-stimulated PAC: OR, 2.098; 95% CI, 0.694-6.339). This study clearly demonstrated that aldosterone responsiveness to ACTH is closely related to previous CCV events. The responsiveness of the PAC to ACTH could be useful in predicting CCV event risk.Registration Number in UMIN-CTR is UMIN000032525.
在原发性醛固酮增多症(PA)中,醛固酮分泌除自主分泌外,还常受促肾上腺皮质激素(ACTH)调节。然而,醛固酮对ACTH刺激有反应的PA患者的临床特征以及心血管和脑血管(CCV)事件风险仍不明确。本研究旨在调查醛固酮对ACTH刺激反应性高的PA患者中CCV事件的发生率。作为日本原发性醛固酮增多症研究/日本罕见难治性肾上腺疾病项目的一部分,进行了一项回顾性横断面研究。纳入2006年1月至2019年3月期间接受肾上腺静脉采样(AVS)的PA患者。AVS期间下腔静脉的ACTH刺激后血浆醛固酮浓度(PAC)用于评估醛固酮对ACTH的反应性。我们分析了反应性与既往CCV事件之间的关系。逻辑回归分析表明,在调整经典CCV事件危险因素、基线PAC和高血压病程后,ΔPAC(ACTH刺激前后PAC测量值之差)显著增加了PA患者既往CCV事件的几率(相对PAC:比值比[OR],2.896;95%置信区间[CI],0.989 - 8.482;ΔPAC:OR,2.344;95%CI,1.149 - 4.780;ACTH刺激后PAC:OR,2.098;95%CI,0.694 - 6.339)。本研究清楚地表明,醛固酮对ACTH的反应性与既往CCV事件密切相关。PAC对ACTH的反应性可用于预测CCV事件风险。UMIN-CTR注册号为UMIN000032525。